Symbol
| AIS
|
Location
| Xq11.21-q12.1
|
Name
|
androgen insensitivity syndrome |
Other name(s)
|
androgen resistance syndrome
. testicular feminization
. Reifenstein syndrome |
Corresponding gene
|
AR
|
Other symbol(s)
| AIS
|
Main clinical features
|
undermasculinization in presence of a 46, XY karyotype and normal testes
. three broad phenotypes corresponding to a spectrum of defects in androgen action :
- complete AIS with typical female genitalia
- partial AIS with predominantly female, predominantly male or ambiguous genitalia
- mild AIS with typical male genitalia |
Genetic determination
| sex linked |
Related entries
| SBMA
|
Function/system disorder
| endocrinology |
Type
| malformation
|
Gene mutation | Chromosome rearrangement | Effect | Comments |
|
---|
missense
|  
|  
| Over 300 point mutations have been found with a majority of missense mutations impairing androgen binding
| nonsense
|  
|  
| truncating mutations in exon 1 almost always cause CAIS
| repeat expansion
|  
|  
| increased CAG repeat length in the infertile males and in moderate to severe undermasculinized genitalia in XY males
| |
Remark(s)
|
expansion of the polyglutamine tract (>40 CAG) causes spinobulbar muscular atrophy (SBMA)
. disrupted N-/C-terminal interaction of AR is capable of providing the mechanism for androgen-insensitivity syndrome in most cases where the mutation in theligand binding domain does not disrupt ligand binding |